These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17554682)

  • 1. Serotonin involvement in the metamorphosis of the hydroid Eudendrium racemosum.
    Zega G; Pennati R; Fanzago A; De Bernardi F
    Int J Dev Biol; 2007; 51(4):307-13. PubMed ID: 17554682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and serotonin modulate the onset of metamorphosis in the ascidian Phallusia mammillata.
    Zega G; Pennati R; Groppelli S; Sotgia C; De Bernardi F
    Dev Biol; 2005 Jun; 282(1):246-56. PubMed ID: 15936344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of the selective ligands of dopamine and 5-hydroxytryptamine receptors on the tolerance to global cerebral ischemia].
    Kulinskiĭ VI; Gavrilov SS
    Eksp Klin Farmakol; 2006; 69(6):20-3. PubMed ID: 17209458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin plays an early role in the metamorphosis of the hydrozoan Phialidium gregarium.
    McCauley DW
    Dev Biol; 1997 Oct; 190(2):229-40. PubMed ID: 9344541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors.
    Parga J; Rodriguez-Pallares J; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Dev Neurobiol; 2007 Jan; 67(1):10-22. PubMed ID: 17443768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A; Kulkarni SK
    Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopamine and serotonin receptor antagonists on fencamfamine-induced abolition of latent inhibition.
    de Aguiar CR; de Aguiar MJ; DeLucia R; Silva MT
    Eur J Pharmacol; 2013 Jan; 698(1-3):246-51. PubMed ID: 23123352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons.
    Ho SS; Chow BK; Yung WH
    Eur J Neurosci; 2007 May; 25(10):2991-3000. PubMed ID: 17561813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 15. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inductive activity of the posterior tip of planula in the marine hydroid Dynamena pumila].
    Kraus IuA
    Ontogenez; 2011; 42(2):116-25. PubMed ID: 21542340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.
    Muñoz A; Carlsson T; Tronci E; Kirik D; Björklund A; Carta M
    Exp Neurol; 2009 Sep; 219(1):298-307. PubMed ID: 19500572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic receptors for dopamine, histamine, and serotonin.
    Feuerstein TJ
    Handb Exp Pharmacol; 2008; (184):289-338. PubMed ID: 18064418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.